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Abstract 
This study evaluated the antimalarial, haematological and biochemical status of Plasmodium berghei Anka 65-
infected mice treated with methanol extract of Peltophorum pterocarpum stem bark (MEPT). The acute toxicity 
profile and phyto-constituents were also evaluated. Thirty mice were divided into 6 groups of 5 mice each. 
Group 1 served as normal control and received distilled water only. Group 2 was parasitized and untreated. 
Groups 3-5 were parasitized and treated with 200, 400 and 600 mg/kg b.w. body weight of MEPT respectively. 
Group 6 was parasitized and treated with 28 mg/kg. b.w. of arthemeter/lumenfantrin combination. Malaria 
parasitemia were monitored on treatment days 0-3. Antioxidant, liver, kidney and lipid peroxidation status were 
determined using classical methods 5 days post-treatment. There were dose-dependent reductions in malaria 
parasitemia percentages of groups 3-5 that are comparable with group 6. In addition, there were dose and 
duration-dependent increases in malaria chemo-suppression in groups 3-5. The existence of oxidative stress, 
lipid peroxidation, and kidney and liver dysfunctions were observed in group 2 when compared with group 1. 
Treatment of groups 3-5 with MEPT and group 6 with arthemeter/lumenfantrin for 4 days restored the 
biochemical anomalies induced by malaria. The extract was tolerable up to 5,000 mg/kg b.w. of MEPT. The 
presence of flavonoids, alkaloids, saponins, tannins, steroids, carotenoids, glycosides, anthraquinones, terpenoids 
and anthocyanins were detected in high amounts while phenols was detected in low amount in MEPT. These 
suggest that MEPT possesses antimalarial activity and normalizes malaria-modified biochemical changes. These 
effects might be attributed to its bioactive constituents. 
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1. Introduction 
Morbidity and mortality to malaria has remained unacceptably high globally and majority of individuals who die 
from malaria are infants, children and pregnant women living in sub-Saharan Africa and Asia (Onaku et al., 
2011; WHO, 2018). Plasmodium species (the causative agent of malaria) affect some organs in the body such as 
liver, kidney and brain causing dysfunctions associated with uncontrolled malaria condition (Dzeing-Ella et al., 
2010). The severity of malaria infection can be determined by measuring the parasite density, haematological 
and biochemical status (such as antioxidant, lipid peroxidation, renal and hepatic status). Clinical manifestation 
of renal involvement in human malaria is associated with infection by P. falciparum and Plasmodium malariae 
(Naqvi et al., 2003), and may be responsible for an immune complex mediated glomerular disease leading to 
nephrotic syndrome. Other renal-associated complications include urinary sediment anomalies, proteinuria, 
electrolyte imbalance, and acute renal failure (ARF) with metabolic acidosis (Padhi and Mishra, 2012). Also, 
renal tubular variations are reported in P. falciparum infection such mild and acute tubular necrosis (ATN) and 
ARF accompanied by frequent oliguria and hypercatabolism (Gomes et al., 2011). ARF can be diagnosed by 
elevated serum creatinine and urea levels (Uzuegbu, 2011; Padhi and Mishra, 2012). The sudden increase in the 
urea level and imbalance in the electrolyte levels such as sodium, potassium, bicarbonate, and chloride in 
patients suffering from malaria could serve as indicators for kidney dysfunction (Jasani et al., 2012). Generally, 
malaria is such a serious issue because it goes with several complications such as oxidative stress (Chikezie and 
Okpara, 2013; Oyewolea et al., 2014), hypoglycemia and hyperinsulinaemia (Elased and Playfair, 1994), 
haematological aberrations (Akin-Osanaiye et al., 2013; Bakhubaira, 2013).   
Liver dysfunction is a common complication that usually occurs in malaria infection. Studies reported a 
sudden increase in serum activities of liver marker enzymes in malaria infected individuals as an indication of 
liver dysfunction (Jarikre et al., 2001; Onyesom and Onyemakonor, 2011). The sporozoite invasion of 
hepatocytes during the exo-erythrocytic stage of malaria parasite life cycle contributes immensely to liver 
dysfunction in malaria (Onyesom, 2012). The presence of sporozoites in the liver during exo-erythrocytic as well 
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as accumulation of haemozoin in the liver during erythrocytic stages of malaria parasite life cycle induces 
immune-mediated damages to the hepatocytes. This causes leakage of parenchymal and membranous enzymes 
of the liver into general circulation, which might be responsible for the increase in serum activities of these liver 
marker enzymes (Burtis and Ashwood, 2001). In addition, the activities of liver marker enzymes and level of 
creatinine has been shown to be correlated with malaria parasite density and hence, severity of malaria infection 
(Onyesom and Onyemakonor, 2011). As a result of high level of complication and death of children and 
pregnant women due to malaria infection, there is need to evaluate the extent of renal and hepatic dysfunctions in 
malaria using animal model so that there will be proper management of malaria infection and its associated 
complication (Ogbadoyi and Tsado, 2009). The challenges posed to man by malaria are worsened by the absence 
of malaria vaccine, inaccessibility and unavailability of effective antimalarials; the antimalarial drugs available 
are expensive and toxic. In addition, there are existence and spread of drug-resistant Plasmodium species 
(Saotoing et al., 2011). This necessitates a continuous effort to search for new drugs and alternatives; one of 
which is the search for plant materials with antimalarial potentials and ameliorative effect on malarial-related 
complications. In addition, there are also needs to add more variety of antimalarial to existing ones to provide 
drugs for individuals who do not tolerate the currently-available antimalarial drugs. 
Peltophorum pterocarpum belongs to the family Leguminosae and is a native to tropical Southeastern Asia 
and an ornamental tree widely distributed around the world including India and Nigeria. Different parts of P. 
pterocarpum are used in the treatment of diseases such as stomatitis, insomnia, constipation and ringworm by 
traditional healers. The flower extract is used to induce sleep and treat insomnia. Its bark is used as medicine for 
dysentery, as eye lotion, embrocation for pains and sores. Traditional healers in Southeastern Nigeria use 
extracts of the plant stem bark to treat malaria (Enechi et al., 2016). Scientific reports recorded that P. 
pterocarpum extracts exhibit high free radicals scavenging activity (Jain et al., 2012), liver protective activity 
(Biswas et al., 2010), hypoglycemic activity (Manaharan et al., 2011), anti-anaemic effect (Enechi et al., 2016), 
antibacterial effect (Jagessar et al., 2007; Ravikumar and Subbu-Raltinan, 2009) and histoprotective effect 
(Karunai et al., 2012). It is therefore necessary to evaluate in addition to its antimalarial activities, the 
ameliorative effects of methanol extract of P. pterocarpum stem bark on Plasmodium berghei-Anka 65-induced 
oxidative stress, and haematological, kidney and liver abnormalities in mice, in order to scientifically validate 
the folkloric use of the plant in the treatment of malaria and its associated complications. 
 
2. Materials and methods 
2.1 Collection, authentication and extraction of plant material  
Fresh stem bark of P. pterocarpum was collected from a Habitat in Nsukka, Enugu State, Nigeria and was 
authenticated at the Herbarium of the Department of Plant Science and Biotechnology, University of Nigeria, 
Nsukka, Enugu State, Nigeria. Stem bark of P. pterocarpum (2.0 kg) was washed, chopped into small pieces, air-
dried for 14 days and powdered mechanically. One kilogram (1.0 kg) of ground coarse sample was macerated in 
5.5 litres of methanol (BDH, England) for 72 h with interval stirring. The suspension was filtered and filtrate was 
concentrated under reduced pressure and dried using a rotary evaporator at 45°C. The dark-brown concentrate 
(henceforth called methanol extract of P. pterocarpum stem back- MEPT) was stored in a dark sterile air-tight 
container at 4-8°C until used. The percentage yield of the extract was 28.15%. 
 
2.2 Acute toxicity study on MEPT 
The acute toxicity profile was assessed by adopting the method of Lorke (1983). This study was carried out in 
two phases and involved a total of 18 albino mice. In the first phase, 9 mice were grouped into 3 groups of 3 
mice each and were orally administered 10, 100 and 1000 mg/kg b.w. of MEPT respectively. The mice were 
observed for 24h for sign of toxicity such as nervousness, dullness, incoordination and/or death. In the second 
phase, 3 groups of 3 mice each orally received 1600, 2900 and 5000 mg/kg b.w. respectively. The mice were 
monitored for 24 h as above and observations were recorded. 
 
2.3 Management of Experimental Animals and Parasite Inoculation 
Experimental animal models used for the study were male albino mice of weight 30-35 g. The mice were 
obtained from the Faculty of Veterinary Medicine, University of Nigeria, Nsukka. Before the experiment, the 
mice were acclimatized under standard laboratory condition in the animal farm of the Department of 
Biochemistry, University of Nigeria, Nsukka for 2 weeks with free access to water and rodent chow ad libitum. 
The experimental procedures followed the institutional, national and international (Pub No.85-23, revised 1985) 
Ethical Guidelines for the Care and Use of Laboratory Animals.  
Donor mouse blood infected with the P. berghei was obtained from the Department of Parasitology, Faculty 
of Veterinary Medicine, University of Nigeria, Nsukka and was used for inoculum preparation. Blood sample 
from the donor mouse was diluted serially in Alsever’s solution so that every 0.2 ml of the suspension will 
contain about 1x107 infected red blood cells (RBCs). Mice in groups 2-6 were each inoculated with 0.2 ml 
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suspension intraperitoneally to initiate infection. Malaria infection was confirmed 72 h post inoculation (day 0). 
All the mice were divided into 6 groups of 5 mice and treated orally with extract and standard drugs as thus: 
Group 1 served as normal uninfected mice treated with 1 ml/kg distilled water (normal control). Group 2 served 
as malaria control (parasitized and untreated mice). Groups 3, 4 and 5 were parasitized mice treated with 200, 
400 and 600 mg/kg b.w. of MEPT respectively (doses previously used by Enechi et al. (2016) were adopted). 
Group 6 were parasitized mice treated with 28 mg/kg. b.w. of arthemeter/lumenfantrin. The level of parasitaemia 
was determined on days 0, 1, 2, and 4. On day 9 (5 days post-treatment), after an overnight fasting, the 
experimental mice were sacrificed and blood samples were collected by ocular puncture into anticoagulated and 
plain tubes. The samples in plain tube were allowed to cloth for 15 min at room temperature after which it was 
centrifuges at 4000 rpm for 10 min. The supernatant (serum) was subjected to biochemical analyses. Samples 
collected in anticoagulated tubes were used for haematological analysis. 
 
2.4 Determination of parasitaemia level  
The levels of parasitaemia in the experimental mice were determined haematologically, using microscopic 
technique of Peters (1967) with slight modification. Thick blood smears were collected daily from tail blood, 
stained with Giemsa’s stain and examined under low powered microscope (x 10 resolution) to determine the 
parasitaemia level. The percentage parasitaemia was determined by counting the parasitized red blood cells out 
of RBCs in random fields of the microscope: 
 
 
2.5 Determination of haematological and biochemical parameters 
Already established methods were adopted for the determination of haematological and biochemical status of the 
experimental mice. The parameters analyzed and methods used include: The cyanomethaglobin and 
haemocytometry methods of Ochei and Kolhatkar (2008) were used to determine the haemoglobin concentration, 
and red blood cells (RBC), white blood cells (WBC) and platelet (PLT) counts respectively. The activities of 
catalase (CAT) (Aebi, 1984), superoxide dismutase (SOD) (Fridovich, 1983), glutathione peroxidase (GPx) 
(Paglia and Valentine, 1962), aspartate aminotransferase (AST) and alanine aminotransferase (ALT) (Reitman 
and Frankel, 1957), and alkaline phosphatase (ALP) (Kochmar and Moss, 1976) were detected. Others include 
concentrations of glutathione (Habig et al., 1974), vitamins A, C (Goodhart and Shils, 1973), and E (Desai, 
1984), malondialdehyde (MDA) (Wallin et al., 1993) and total bilirubin (Jendrassik and Grof, 1938). The 
determination of urea level in serum was done using the Urease Berthelot method of Fawcett and Scott (1960). 
Serum creatinine level was determined based on the Jaffe’s alkaline picrate reaction using direct endpoint 
method of Henry (1974). The enzymatic method outlined by Milena et al. (2003) was used for the determination 
of uric acid level.  
 
2.6 Phytochemical screening of the extract 
The methods earlier reported by Harbone (1973) and Trease and Evans (1989) were adopted in this study to 
screen for the presence of flavonoids, alkaloids, saponins, tannins, steroids, carotenoids, glycosides, 
anthraquinones, terpenoids, anthocyanins and phenols in the extract. 
 
2.7 Statistical analysis 
One-way analysis of variance (ANOVA) was employed to compare means across the test and control groups. 
Primary data from the laboratory were analyzed in IBM Statistical Product and Service Solutions (SPSS) 
software, version 16. Mean values with p < 0.05 were considered statistically significant. 
 
3. Results 
3.1 Acute toxicity profile of MEPT 
The acute toxicity test of MEPT showed that the extract is tolerable; there was neither mortality nor sign of 
toxicity at doses up to 5,000 mg/kg per body weight of the extract (Table 1). This result implies that the LD50 is 
above 5,000 mg/kg b.w.  
 
3.2 Effect of MEPT on the malaria parasitaemia and malaria parasite chemo-suppression  
As shown in Table 2, mice in group 2 (infected and untreated) had a significantly (p < 0.05) higher malaria 
parasitaemia compared with animals in control, and infected and treated groups (On day 1, 24 hr post-treatment). 
From days 0-3, the percentage malaria parasitaemia of mice in group 2 were increased significantly (p < 0.05) 
while those of animals in groups 2-6 had significant (p < 0.05) reduction. This implies that infection with malaria 
increased the malaria parasitaemia in mice if left untreated as seen in group 2 compared to group 1. Also, the 
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reduction in malaria parasitaemia in mice treated with MEPT was dose-dependent and was comparable with 
standard drug (arthemeter/lumenfantrin). Similarly, there was a dose and duration-dependent increase in 
percentage malaria chemo-suppression in malaria-parasitized and extract-treated mice.  
Table 1: The acute toxicity profile of MEPT 
Group Dosage ( in mg/kg b.w) Mortality  
Phase I 
Group 1 10 0/3 
Group 2 100 0/3 
Group 3 1000 0/3 
Phase II 
Group 1 1600 0/3 
Group 2 2900 0/3 
Group 3 5000 1/3 
Median Lethal dose (LD50) = 3807.89 mg/kg b.w 
 
Table 2: Effect of MEPT on malaria parasitaemia and malaria parasite chemo-suppression  
Groups/ 
Duration 
Day 0 
(%) 
Day 1 
(%) 
Day 2 
(%) 
Day 3 
(%) 
Day 1 Chemo- 
suppression 
(%) 
Day 2 Chemo- 
suppression 
(%) 
Day 3 Chemo- 
suppression 
(%) 
Group 1 0.00± 0.00 0.00± 0.00 0.00± 0.00 0.00± 0.00 - - - 
Group 2 46.50 ± 5.01a 76.00 ± 2.16a 83.50 ± 3.70a 87.75 ± 5.56a - - - 
Group 3 48.00 ± 10.12a 41.50 ± 3.10b 39.25 ± 7.27b 30.00 ± 6.27b 24.75 ± 6.23b 20.71 ± 4.42a 37.37 ± 2.12a 
Group 4 57.25 ± 7.18ab 40.50 ± 6.03c 35.00 ± 6.06bc 25.25 ± 4.57c 32.75 ± 3.17c 45.85 ± 1.91b 57.64 ± 3.36b 
Group 5 52.40  ± 5.08ab 38.25 ± 7.63c 27.25 ± 4.27c 20.00 ± 3.16d 34.05 ± 2.43c 53.01 ± 2.20c 70.69 ± 1.62c 
Group 6 56.50 ± 5.80b 48.50 ± 6.19c 26.25 ± 3.30c 15.25 ± 2.30d 19.50 ± 1.84a 56.43 ± 3.43c 74.69 ± 4.28c 
Data are mean ± standard deviation (SD) (n = 5). Values with different superscript down the column are 
statistically significant at p < 0.05.  
 
3.3 Effects of MEPT on the haematological indices of malaria-infected mice 
The results of the packed cell volume (PCV), haemoglobin (HB) concentration, red blood cell (RBC), white 
blood cell (WBC) and platelets count of experimental animals are shown in Table 3. Mice infected with P. 
berghei and untreated (group 2) have significantly (p < 0.05) lower PCV level, Hb concentration, RBC, WBC 
and PLT counts when compared with normal control. Treatment of parasitized mice with graded doses of extract 
(groups 4-6) and artesunate (group 3) significantly (p < 0.05) increased all the haematological parameters 
towards normal when with group 2. 
Table 3: Effects of MEPT on the haematological indices of malaria parasitized mice 
Groups PCV (%) HB (g/L) WBC (mm-3) RBC (X106/L) Platelets (X109/L) 
Group 1 40.75 ± 3.20b 13.63 ± 1.11b 6200 ± 495.31b 236.25 ± 4.79e 130.00 ± 5.89c 
Group 2 28.50 ± 2.38a 9.38 ± 0.75a 5800 ± 565.69a 151.25 ± 8.54a 99.50 ± 4.20a 
Group 3 37.75 ± 1.71b 12.38 ± 0.48b 6075 ±170.78b 190.00 ± 9.13b 117.00 ± 2.58b 
Group 4 38.75 ± 1.50b 12.63 ± 0.48b 6600 ± 230.94b 216.25 ± 4.79d 147.00 ± 9.75d 
Group 5 42.75 ± 1.89b 14.13 ± 0.75b 7850 ± 424.70c 228.25 ± 6.24e 210.75 ± 3.77e 
Group 6 40.50±1.00b 13.25±0.50b 8400±163.30d 205.00±7.07c 145.00 ± 3.83d 
Data represent mean ± standard deviation (SD) (n = 4). Values with different superscripts are considered 
significantly different at p < 0.05. MEPT= methanol extract of P. pterocarpum stem bark 
 
3.4 Effects of MEPT on antioxidant and lipid peroxidation status of parasitized mice 
Malaria infection significantly (p< 0.05) reduced the activities of antioxidant enzymes (GPx, CAT and SOD) of 
parasitized and untreated mice (group 2) when compared with mice in group 1 (normal control). Treatment of 
parasitized mice with extract and standard drug (groups 3, 4, 5 and 6 respectively) ameliorated the reduced 
antioxidant activities when compared to the mice in group 2. Similarly, malaria parasitized and untreated mice 
(group 2) had significantly (p<0.05) lower concentrations of antioxidant vitamins (vitamins A, C and E) when 
compared with those of group 1. However, treatment of parasitized mice with methanol extract and standard 
drug significantly (p<0.05) elevated the concentrations of antioxidant vitamins towards normal control mice 
when compared to those of infected and untreated (Table 4). In the same vein, infection of mice with malaria 
parasites significantly (p<0.05) reduced the glutathione (GSH) concentration of mice in group 2 when compared 
to those of group 1. Meanwhile, there were significantly (p<0.05) higher GSH concentrations in parasitized and 
extract- and standard drug-treated mice when compared with those of mice in group 2. On the other hand, 
parasitized and untreated mice had significantly (p<0.05) higher malondialdehyde (MDA) concentrations 
compared with those of mice in group 1. Malaria parasitized and extract- and standard drug-treated mice had 
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lower MDA concentration when compared with those of mice in group 2. There was no significant (p>0.05) 
difference among the MDA levels of mice in groups 1, 3, 4, 5 and 6 which mean that the extract was able to 
restore the lipid peroxidation level to normal (Table 4).  
 
3.5 Effects of MEPT on the liver and kidney status of parasitized mice  
Malaria parasitized and untreated mice (group 2) had significantly (p<0.05) higher activities of liver function 
enzymes (ALT, AST and ALP) and concentration of total bilirubin when compared with those of group 1. 
However, treatment of parasitized mice (groups 3-6) with methanol extract and standard drug significantly 
(p<0.05) decreased the activities of liver function enzymes (ALT, AST and ALP) and concentration of total 
bilirubin when compared to those of infected and untreated (Table 4). It was also observed that malaria 
parasitized and untreated mice (group 2) had significantly (p<0.05) higher renal function markers (creatinine, 
urea and uric acid) concentrations when compared with those of group 1. However, treatment of parasitized mice 
with methanol extract and standard drug (groups 3-5 and 6 respectively) significantly (p<0.05) decreased the 
concentrations of renal function markers (creatinine, urea and uric acid) when compared to the infected and 
untreated mice (group 2) (Table 5).  
Table 4: Effects of MEPT on the antioxidant and lipid peroxidation status of parasitized mice 
Groups Antioxidant Enzymes Activities (IU/l) Antioxidant Vitamins Concentrations Lipid peroxidation 
Glutathione 
Peroxidase 
Catalase Superoxide 
Dismutase  
Vitamin A 
(mg/dl) 
Vitamin C 
(mmol/l) 
Vitamin E 
(mmol/l) 
GSH 
(mmol/l) 
MDA 
(mmol/l) 
Group 1 17.05 ± 0.67b 2.78 ± 0.19b 11.05 ± 0.13c 18.88 ± 1.47b 4.85 ± 0.37b 0.15 ± 0.01b 1.23 ± 0.03b 4.68 ± 0.86b 
Group 2 6.46 ± 1.41a 1.82 ± 0.10a 8.83 ± 0.60a 11.41 ± 0.78a 3.85 ± 0.64a 0.09 ± 0.00a 1.05 ± 0.02a 7.75 ± 1.44a 
Group 3 18.68 ± 1.16b 2.49 ± 0.48b 10.30 ± 0.34b 18.65 ± 0.74b 5.03 ± 0.57bc 0.13 ± 0.01b 1.12 ± 0.05b 5.15 ± 0.13b 
Group 4 19.47 ± 0.41b 2.90 ± 0.37b 10.68 ± 0.17b 19.01 ± 1.04b 5.55 ± 0.37bc 0.13 ± 0.01b 1.39 ± 0.04c 4.53 ± 0.26b 
Group 5 21.49 ± 1.58c 2.73 ± 0.58b 11.65 ± 0.55c 20.39 ± 0.70b 6.90 ± 0.32c 0.14 ± 0.01b 1.86 ± 0.04d 4.40 ± 0.36b 
Group 6 17.36 ± 1.17b 2.72 ± 0.23b 10.20 ± 0.55b 18.83 ± 1.22b 5.83 ± 0.40bc 0.14 ± 0.01b 1.41 ± 0.09c 4.68 ± 0.17b 
Data were mean ± standard deviation (SD) (n = 5). Values with different superscripts down the column are 
statistically significant at p < 0.05. GSH = Glutathione; MDA = Malondialdehyde 
Table 5: Effects of MEPT on the liver and kidney status of parasitized mice 
Groups Biomarkers of liver status Biomarkers of liver status 
AST  
(IU/l) 
ALT  
(IU/l) 
ALP  
(IU/l) 
T. Bil  
(mg/dl) 
Creatinine 
(mmol/l) 
Urea  
(mg/dl) 
Uric acid 
(mmol/l) 
Group 1 59.00 ± 4.32a 11.75 ± 0.96a 22.00 ± 8.60a 0.70 ± 0.08b 0.88 ± 0.07b 24.00 ± 0.82b 4.23 ± 0.54a 
Group 2 79.00 ± 3.16c 25.75 ± 1.71d 37.00 ± 1.83b 2.18 ± 0.13d 1.12 ± 0.14c 29.75 ± 0.96c 6.70 ± 0.37c 
Group 3 66.50 ± 2.65b 14.25 ± 1.26c 24.25 ± 0.96a 1.00 ± 0.08c 0.76 ± 0.08b 20.75 ± 0.96a 4.58 ± 0.19a 
Group 4 59.00 ± 3.37a 13.25 ± 0.96b 23.75 ± 0.96a 0.75 ± 0.06b 0.76 ± 0.03b 21.00 ± 0.82a 4.40 ± 0.22a 
Group 5 56.00 ± 4.32a 11.00 ± 0.82a 21.25 ± 1.71a 0.66 ± 0.05a 0.80 ± 0.03b 20.50 ± 1.29a 4.35 ± 0.41a 
Group 6 54.50 ± 4.20a 12.75 ± 0.96ab 24.75 ± 1.71a 0.90 ± 0.18c 0.90 ± 0.03b 25.00 ± 0.82b 5.33 ± 0.40b 
Data were mean ± standard deviation (SD) (n = 4). Values with different superscript down the column are 
statistically significant at p < 0.05. AST = Aspartate aminotransferase; ALT = Alanine aminotransferase; ALP = 
Alkaline phosphatase; T. Bil = Total bilirubin  
 
3.6 Phytochemical constituents of MEPT 
The presence of flavonoids, alkaloids, saponins, tannins, steroids, carotenoids, glycosides, anthraquinones, 
terpenoids and anthocyanins were detected in high amounts while phenols was detected in low amount in 
methanol extract of P. pterocarpum stem bark (Table 6). 
Table 6: Phytochemical constituents of MEPT 
Phytochemicals  Bioavailability 
Saponins +++ 
Tannins +++ 
Alkaloids +++ 
Flavonoids +++ 
Glycosides +++ 
Terpenoids +++ 
Phenols + 
Steroids +++ 
Carotenoids +++ 
Anthraquinones +++ 
Anthocyanins +++ 
Key: +++ = high content; ++ = moderate content; + = low content 
 
4. Discussion 
The present study evaluated antimalarial activity and possible ameliorative effects of MEPT on the biochemical 
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status of Plasmodium berghei Anka 65-parasitized mice. The reduction in malaria parasitaemia and increase in 
malaria parasite chemo-suppression by MEPT shows that it has antimalarial activity which is comparable with 
the standard artemisinin-combination therapy (ACT) antimalarial drug (arthemeter/lumenfantrin) used in this 
study. This finding agrees with our earlier report that methanol extract of this plant root has antimalarial activity 
and normalized malaria-modified haematological indices (Enechi et al., 2016). Bergenin, a sesquiterpene lactone 
compound, isolated from P. pterocarpum flowers has been shown to possess antimicrobial activity (Raj et al., 
2012) while the antimalarial activity of berginin derived from Rodgersia aesculifolia Batal was reported (Liang 
et al., 2014). 
Anaemia is a fairly common problem encountered in malaria. Czaja et al. (2002) reported that anaemic 
condition can be characterized by haemoglobin (Hb) concentration of less than 13 g/dl. In the present study, the 
infected and untreated mice (group 2) had mean Hb concentration less than 13 g/dl (indicating the presence of 
anaemia). The Hb concentration of group 2 mice was significantly (p < 0.05) lower than that of the control 
(group 1). Treatment of the infected rats with graded doses of MEPT (groups 3-5) restored the Hb concentration 
relative to group 1. The observed anaemia in P. berghei-infected mice may be due to RBC destruction caused 
either by parasite multiplication or by spleen reticuloendotelial cell action (Chinchilla et al., 1998). This decrease 
may also be due to repeated haemolysis of infected red cells is the most important. The haemolysis may be due 
to non-immune destruction of parasitized red cells in case of high parasitaemia as well as immune mediated 
destruction of parasitized as well as non-parasitized red blood cells. This is because changes in the red blood cell 
antigen structure brought about by the parasitic invasion may stimulate the production of antibodies against the 
red cell. This consequently triggers immune-mediated lysis of the red cell (Kotepui et al., 2014). In addition, the 
growing parasite consumes and degrades haemoglobin which may account for further decrease in Hb. in the 
same vein, malaria infection has been shown to suppress erythropoiesis (Jadhav et al., 2004). These decreases 
however, were considerably reversed in the parasitized and MEPT as well as parasitized and artesunate-treated 
mice after 4th day of treatment. This suggests that there may be total restoration in Hb and PCV levels and RBC 
counts, if monitored for further duration. The findings also suggest that the plant extract may have some 
stimulatory effect on the production of red blood cells which might have contributed to the increase in Hb 
concentration, PCV levels and WBC count as observed in the infected and MEPT-treated mice. More so, 
components of some plant extracts have been shown to boost erythropoiesis (Nwinuka et al., 2008). These 
results suggest that MEPT might be useful in managing anaemia. Leucopenia was observed in parasitized and 
untreated mice (group 2 mice). This agrees with the reports of Singh et al. (2014) that malaria induces anaemia, 
leucopenia, thrombocytopenia, and other haematological abnormalities. Malaria-induced thrombocytopenia 
might have resulted from either parasite antigen-programmed splenic destruction of platelets and/or suppression 
of thrombopoiesis by parasite antigen that infiltrates into the bone marrow (Morell, 2014; Srivastava et al., 2017). 
The increase in WBC of parasitized mice upon treatment with MEPT suggests that the extract is 
immunostimulatory in action. Similarly, the ability of the extract to increase the platelet count in the parasitized 
and extract-treated mice shows that is has stimulatory action on thrombopoiesis. 
Parasitized and untreated mice had lower antioxidant enzymes (GPx, CAT and SOD) activities when 
compared with normal rats. The human endogenous antioxidant enzymes (such as GPx, GST, CAT and SOD) 
and non-enzymatic enzymes (such as GSH, a coenzyme required for GPx activity) makes up the inherent human 
antioxidant system which protects the cells from oxidative damages by scavenging free radicals responsible for 
oxidation of cellular components. SOD, a metalloprotein enzyme involved in antioxidant defense, acts by 
lowering the steady state level of superoxide anion radical (∙O2-), converting it to hydrogen peroxide (H2O2) 
while CAT protects cells against radical toxicity by catalyzing the decomposition of H2O2 to water and molecular 
oxygen. During oxidative stress, as seen in malaria, free radical production is increased. Free radicals attack and 
damage cellular components, some of which are DNA, lipids, carbohydrates and proteins. When such damaged 
proteins are membrane proteins, receptors or even transport proteins, loss of function is bound to occur. Also, 
free radicals such as H2O2 attack thiol functional groups of side chain amino acids of enzymes, causing loss of 
enzyme activity. This could explain the reduced activity of the antioxidant enzymes as seen in the present study. 
Additionally, decreased levels of SOD and CAT in the malaria-infected and untreated mice may be due to the 
overuse of these enzymatic antioxidants to control malarial-induced free radical production.  
The level of lipid peroxidation is an indication of membrane damage; alterations in its structure and 
function, and is measured by the level of MDA. Erythrocytes are more vulnerable to lipid peroxidation due to 
high unsaturated fatty acid content of the membrane and lower antioxidant capacity (Anandan et al., 1999). A 
significantly higher mean MDA level was observed in the parasitized and untreated mice (group 2) when 
compared with normal mice (group 1). This result suggests the existence of oxidative stress in malaria. Oxidative 
stress may have resulted from the release of intermediates of plasmodial attack on cellular components, and 
breakdown products of haemoglobin such as heme and free ferrous ion. These products are free radicals and free 
radical-producing agents (via Fenton and Harber-Weiss reactions) respectively. The reduction in activities of 
antioxidant enzymes in group 2 mice when compared with group 1 could also be due to the cross-linking of these 
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enzymes with MDA (Eritsland et al., 2000). Reports have suggested the existence of oxidative stress in malaria; 
markers of oxidative stress were found to be elevated in infected humans and rodents compared to uninfected 
controls (Sobolewski et al., 2005; Cabrales et al., 2011). This reinforces the suggestion that oxidative stress plays 
a major role malaria infection and its associated complications. Also, cells of host immune system (phagocytes) 
produce free radicals to attack and kill malaria parasite during invasion. Some of these free radicals produced, 
especially hydrogen peroxide, can travel from the point of production to other sites, causing cellular damage to 
both the host and foreign cells (Cabrales et al., 2011). Treatment of parasitized mice with extract and standard 
drug for 4 days significantly (p<0.05) reduced the percentage malaria parasitaemia and reduced MDA 
concentrations, and increased malaria parasite chemo-suppression and antioxidant enzymes activities towards the 
normal control. This implies that the extract has antimalarial and antioxidant activities.  
Malaria infection resulted in lower concentrations of antioxidant vitamins (vitamins A, C and E) as seen in 
parasitized and untreated mice when compared with normal control. The lower values observed in antioxidant 
vitamin levels in malaria may be attributed to increased utilization of the hosts serum antioxidants by malaria 
parasites to counteract oxidative damage (Akpotuzor et al., 2007). It may also be linked to the mobilization of 
such antioxidants to scavenge free radicals produced during malaria invasion by the host cells. Report also 
showed that antioxidants such as carotenoids, vitamins C and E could provide protection against oxidative stress 
induced by malaria (Adelekan et al., 1997) and hence, may be lowered during malaria infection. It was observed 
that the higher the level of parasitaemia, the lower the concentrations of these antioxidant vitamins. Treatment of 
parasitized mice with methanol extract and standard drug significantly (p<0.05) increased the antioxidant 
vitamins concentrations towards normal control mice when compared to infected and untreated mice. The 
implication of this finding is that MEPT, which has exhibited both antioxidant and antimalarial effects, may be 
better option in managing of malaria. Our findings also suggest that inclusion of antioxidant agents as one of the 
regimen drugs particularly vitamin C because of its ability to act even in lipid and water medium as well as its 
availability and affordability may be quite beneficial in treatment of malaria patients. However, this must be 
done after treatment with antimalarial drug to avoid counter reaction. Further study to verify this approach, 
especially days after malaria treatment is warranted. 
The pathogenesis of this parasite infection involves the liver stage where sporozoites invade and multiply in 
hepatocytes and an erythrocyte stage where merozoites cause the destruction of the infected red blood cells prior 
to their differentiations into male and female gametocytes. This leads to significant alterations in host hepatocyte 
physiology and morphology (Strickland, 1991). The increase in serum ALT, AST and ALP activities in 
parasitized and untreated mice when compared with those of normal control in this study shows that malaria 
parasite infection may be responsible for the increase in the activities of the liver enzymes, which may lead to 
liver dysfunction. Our result agrees with previous reports that plasmodial infection increase serum liver enzymes 
activities (Onyesom, 2012; Akambi, 2015). The elevated enzymes activities correlate with level of parasitaemia, 
which suggests that the level of liver dysfunction may be determined by the level of parasitaemia. This study 
agrees with the previous study which showed a positive correlation between the level of liver dysfunction and 
parasitaemia (Onyesom and Onyemakonor, 2011).  
The invasion and development of the malaria parasite into the liver during the life cycle may be responsible 
for liver dysfunction by causing membrane damage, resulting in enzyme leakage, organ congestion, cellular 
inflammation, and sinusoidal blockage (Anyasor and Olorunsogo, 2011). Chikezie and Okpara (2013) showed 
the presence of hepatic dysfunction in malaria infection. Malaria parasitaemia engenders increased red blood cell 
haemolysis, which is associated with increase in bilirubin biosynthesis, hepatocellular damage, biliary tract 
obstruction and jaundice (Yokoto and Elisei, 2006). Higher total bilirubin concentration was observed in the 
parasitized and untreated mice when compared with those of normal and parasitized MEPT/standard drug-treated 
mice. The observed high serum bilirubin level indicates the possibility of intrahepatic cholestasis. Centribular 
damage in acute malaria infection is the major cause high serum bilirubin level, an indication of loss of drainage 
action by the liver (Yokoto and Elisei, 2006).  
Accumulation of both conjugated and unconjugated bilirubin and bile acid is implicated in the development 
acute renal failure (ARF) in malaria (Prakash et al., 1996). Meanwhile, treatment of parasitized mice with MEPT 
and standard drug significantly (p<0.05) decreased the activities of liver function enzymes (ALT, AST and ALP) 
and concentration of total bilirubin in serum when compared with infected and untreated mice. This suggests that 
MEPT possess hepatocurative and ameliorative effect on hepatic dysfunction induced by malaria infection. 
Malaria parasitized and untreated mice had significantly (p<0.05) higher serum concentrations of renal function 
markers (creatinine, urea and uric acid) when compared with normal mice. The observed increase in creatinine, 
urea and uric acid in the parasitized and untreated group could be a result of sequestration of the parasite into the 
renal microvasculature bed which may lead to ischemia (Zaki et al., 2013). This indicates that mice with hyper-
parasitaemia may be more likely to have transient renal dysfunction which could be limited for the period of the 
infection. The elevated serum creatinine, urea ad uric acid may be due to accumulation as a result of reduction in 
the clearance during acute malaria infection by the affected kidneys which may return to normal levels after 
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recovery (Mishra et al., 2007). The severity ARF, one of the serious complications of malaria is dependent of the 
level of parasitaemia; ARF in malaria is observed only in subjects with heavy parasitaemia (Boonpucknavig and 
Sitprija, 1979). Parasitized erythrocytes are rigid and have decreased deformability leading to slower flow in the 
microcirculation. Viscosity of parasitized RBCs is also increased leading to increased viscosity of whole-blood 
(Prakash et al., 1996). Findings of these study showed that treatment of parasitized mice with MEPT (groups 3-5) 
and standard drug (group 6) significantly (p<0.05) decreased the concentrations of renal function markers 
(creatinine, urea and uric acid) when compared to those of parasitized and untreated mice (group 2). This 
suggests that the methanol extract possess nephrocurative effect on renal dysfunction induced by malaria 
infection. 
Natural polyphenols from plants have been found to scavenge free radicals, chelate metal ions that 
participate in Fenton-type reaction and activate antioxidant enzymes (Ayoola et al., 2008). Alkaloids and 
saponins have been shown to bacteriocidal, antiplasmodial and antispasmodic effects (Tarawneh et al., 2010). 
The antimalarial activity and ameliorative effects of MEPT on malaria-induced biochemical alterations in this 
study could be attributed to the phytochemical constituents such as alkaloids, flavonoids, steroids among others 
detected in the extract. Some of these phyto-constituents have been shown to possess antimalarial and 
antioxidant activities (Chierrito et al., 2014), and modulatory effects on nephrotoxicity and hepatotoxicity.  
 
5. Conclusion 
In general, findings from the present study demonstrated that methanol extract of P. pterocarpum stem bark 
(MEPT), in addition to its antimalarial activity, normalized oxidative stress, lipid peroxidation, and kidney and 
liver abnormalities induced by Plasmodium berghei Anka-65 infection. The active pharmacological principles in 
MEPT need to be isolated and subjected to clinical trials for malaria treatment. This may provide leads for the 
development of new antimalarial drug.  
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